First Time Loading...

Pro Medicus Ltd
ASX:PME

Watchlist Manager
Pro Medicus Ltd Logo
Pro Medicus Ltd
ASX:PME
Watchlist
Price: 103.75 AUD 1.18% Market Closed
Updated: Mar 29, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Pro Medicus Ltd

Revenue
146.2m AUD
Cost of Revenue
-430k AUD
Gross Profit
145.8m AUD
Operating Expenses
-45.5m AUD
Operating Income
100.3m AUD
Other Expenses
-30.6m AUD
Net Income
69.7m AUD

Margins Comparison
Pro Medicus Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
AU
Pro Medicus Ltd
ASX:PME
10.8B AUD
100%
69%
48%
US
Veeva Systems Inc
NYSE:VEEV
37.3B USD
71%
18%
22%
US
Cerner Corp
NASDAQ:CERN
27.9B USD
83%
13%
10%
JP
M3 Inc
TSE:2413
1.5T JPY
59%
29%
20%
MY
Ucrest Bhd
KLSE:UCREST
45.4B MYR
38%
37%
37%
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD
59%
3%
-2%
US
Inspire Medical Systems Inc
NYSE:INSP
6.3B USD
85%
-6%
-3%
US
Doximity Inc
NYSE:DOCS
5B USD
89%
35%
29%
US
Evolent Health Inc
NYSE:EVH
3.7B USD
23%
1%
-7%
SE
Sectra AB
STO:SECT B
39.9B SEK
49%
-39%
26%
US
Certara Inc
NASDAQ:CERT
2.9B USD
60%
2%
-16%
Country AU
Market Cap 10.8B AUD
Gross Margin
100%
Operating Margin
69%
Net Margin
48%
Country US
Market Cap 37.3B USD
Gross Margin
71%
Operating Margin
18%
Net Margin
22%
Country US
Market Cap 27.9B USD
Gross Margin
83%
Operating Margin
13%
Net Margin
10%
Country JP
Market Cap 1.5T JPY
Gross Margin
59%
Operating Margin
29%
Net Margin
20%
Country MY
Market Cap 45.4B MYR
Gross Margin
38%
Operating Margin
37%
Net Margin
37%
Country US
Market Cap 9B USD
Gross Margin
59%
Operating Margin
3%
Net Margin
-2%
Country US
Market Cap 6.3B USD
Gross Margin
85%
Operating Margin
-6%
Net Margin
-3%
Country US
Market Cap 5B USD
Gross Margin
89%
Operating Margin
35%
Net Margin
29%
Country US
Market Cap 3.7B USD
Gross Margin
23%
Operating Margin
1%
Net Margin
-7%
Country SE
Market Cap 39.9B SEK
Gross Margin
49%
Operating Margin
-39%
Net Margin
26%
Country US
Market Cap 2.9B USD
Gross Margin
60%
Operating Margin
2%
Net Margin
-16%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Pro Medicus Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
AU
Pro Medicus Ltd
ASX:PME
10.8B AUD
50%
36%
59%
87%
US
Veeva Systems Inc
NYSE:VEEV
37.3B USD
13%
10%
10%
22%
US
Cerner Corp
NASDAQ:CERN
27.9B USD
14%
8%
12%
10%
JP
M3 Inc
TSE:2413
1.5T JPY
15%
11%
19%
20%
MY
Ucrest Bhd
KLSE:UCREST
45.4B MYR
20%
15%
20%
46%
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD
-2%
-1%
1%
1%
US
Inspire Medical Systems Inc
NYSE:INSP
6.3B USD
-4%
-3%
-7%
-32%
US
Doximity Inc
NYSE:DOCS
5B USD
15%
13%
18%
47%
US
Evolent Health Inc
NYSE:EVH
3.7B USD
-14%
-6%
1%
0%
SE
Sectra AB
STO:SECT B
39.9B SEK
34%
17%
-48%
-26%
US
Certara Inc
NASDAQ:CERT
2.9B USD
-5%
-4%
0%
0%
Country AU
Market Cap 10.8B AUD
ROE
50%
ROA
36%
ROCE
59%
ROIC
87%
Country US
Market Cap 37.3B USD
ROE
13%
ROA
10%
ROCE
10%
ROIC
22%
Country US
Market Cap 27.9B USD
ROE
14%
ROA
8%
ROCE
12%
ROIC
10%
Country JP
Market Cap 1.5T JPY
ROE
15%
ROA
11%
ROCE
19%
ROIC
20%
Country MY
Market Cap 45.4B MYR
ROE
20%
ROA
15%
ROCE
20%
ROIC
46%
Country US
Market Cap 9B USD
ROE
-2%
ROA
-1%
ROCE
1%
ROIC
1%
Country US
Market Cap 6.3B USD
ROE
-4%
ROA
-3%
ROCE
-7%
ROIC
-32%
Country US
Market Cap 5B USD
ROE
15%
ROA
13%
ROCE
18%
ROIC
47%
Country US
Market Cap 3.7B USD
ROE
-14%
ROA
-6%
ROCE
1%
ROIC
0%
Country SE
Market Cap 39.9B SEK
ROE
34%
ROA
17%
ROCE
-48%
ROIC
-26%
Country US
Market Cap 2.9B USD
ROE
-5%
ROA
-4%
ROCE
0%
ROIC
0%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More